Comment

Neuroscience innovation
#Brain #Comment #Events #Neuroscience #Neuroscience 2024 #Society for Neuroscience

Reflections from SfN’s Neuroscience 2024 

DDW’s Multimedia Editor Megan Thomas attended the Society for Neuroscience (SfN)’s Neuroscience 2024 in October 2024 in Chicago, US. Having attended a range of presentations, explored the exhibition and engaged with industry attendees, she reflects on the event.   News updates  Whilst Neuroscience 2024 took place,… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Carbon emissions #Climate change #Clinical trial design #Comment #Funding #Life sciences #Pharma #Psychedelics #Start-ups

Podcast: The future climate and landscape for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “The future climate and landscape for drug discovery” which covers three written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Pharma’s important climate and What will the… Read More

#News

Genesis 2024
#Biodollar #Business #Comment #Funding #Genesis 2023 #Innovation #Life science

Comment: Reflections from Genesis 2023 

The annual Genesis conference took place at the end of 2023 in London, bringing together key opinion leaders, investors and innovators from across the life sciences sector to exchange insights, debate trends and generate deals. DDW’s Megan Thomas attended and reflects on highlights of the programme.  Stacking… Read More

#Business & Investment #Exclusive Content #Opinion

#AACR #AACR 2023 #Cancer #Cancer research #Comment #Events

Reflections from AACR 2023

DDW’s Megan Thomas provides highlights from AACR 2023, the American Association of Cancer Research’s annual meeting from 14-19 April 2023 in Orlando, Florida, US.  Meet the incoming AACR President  Having said goodbye and thank you to Dr Lisa Coussens, AACR President for 2022-2023, Dr Philip… Read More

#Exclusive Content #Opinion

Biotechnology
#Biotechnology #Comment #Events #Genomics #LSX World Congress

Comment: LSX World Congress 2023 

The LSX World Congress 2023 took place at the Business Design Centre in London, UK in May 2023. DDW’s Megan Thomas comments on the event.   New approaches to partnering   In this event in the Biotech track, Clive Cookson, Science Editor at the Financial Times, interviewed… Read More

#Exclusive Content #Opinion

Science connection and networking
#Biopharmaceuticals #BioTrinity #Comment #Events #Funding #Investment #Life sciences

Reflecting on BioTrinity 2023  

BioTrinity 2023 marked the 17th annual edition of BioTrinity and took place in London, UK from Tuesday 25 April to Wednesday 26 April. DDW’s Megan Thomas spoke with attendees, and comments on the event.    Fundraising and investment   Coming out of a global pandemic, in-person events initially… Read More

#Exclusive Content

European Commission
#Biosimilars #Comment #European Commission #Opinion #Pharma #Regulatory

European Commission vs Big Pharma, or profit vs access?  

On January 31 2023, an internally circulated version of the European Commission’s overhaul of the EU’s pharma legislation was leaked, and published by Politico1. Politico published a summary of the key propositions outlined in the draft2, and DDW’s Multimedia Editor Megan Thomas investigates their intention,… Read More

#Exclusive Content #Opinion #Regulatory

#AI #Biopharma #Biopharmaceuticals #Comment #DNA #Lab automation #SLAS2022 #Synthetic biology

Podcast: The impact of synthetic biology and collaboration in pharma

This is the latest episode of the free DDW podcast. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “Why synthetic biology is the next big thing for biopharma” and “Collaborative spirit helps drive innovation”. ‘Can synthetic biology save… Read More

#News

#Carbon emissions #Climate change #Comment #Life sciences #Pharma

Pharma’s important climate

Listen to this article on the DDW podcast: By DDW Editor Reece Armstrong The looming threat of global warming, consequences of which can already be seen and felt across the planet, will impact us all. It seems that despite a constant barrage of warnings by scientists and… Read More

#Exclusive Content #Opinion

Eye
#Clinical trials #Comment #Covid-19 #Eye #Eye health #Ophthalmology

New narrated podcast on ophthalmology

This is the latest episode of the free DDW podcast, “A deep dive into the future of ophthalmology”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “Innovation, investment and commitment: Genentech’s approach to the future of ophthalmology” and “… Read More

#News

#Biologics #Cell and gene therapy #Clinical research #Comment #FDA #Regulatory

The significance of FDA industry guidance on cell and gene therapies 

On 4 November 2022, the FDA’s Center for Biologics Evaluation and Research released guidance for the industry on studying multiple versions of a cellular or gene therapy (CGT) product in an early-phase clinical trial in a single disease1. This guidance finalises the draft guidance of the same… Read More

#Exclusive Content #Opinion #Regulatory

Genomics
#Biotechnology #Comment #Data #Gene editing #Genetics / genomics #Genome sequencing #Healthcare #Public health #Research #Whole genome sequencing

Why genomic healthcare data matters in the development of new therapies 

Genomic healthcare data is critical to identify disease risk, ancestry, traits and response to medicines and aids in the development of new targeted therapies – precision medicines. DDW’s Megan Thomas observes developments of accessibility in this sector and the potential impact.  The origins  One might… Read More

#Exclusive Content #Opinion #Trends & Analysis

#Comment #Drug Discovery 2022 #ELRIG #Events

Reflecting on ELRIG’s Drug Discovery 2022 

The DDW team spent 4-5 October, 2022 at ELRIG’s annual meeting, Drug Discovery 2022, which remains Europe’s largest meeting for life sciences industry professionals and took place at ExCel, London, UK. DDW’s Megan Thomas comments on the presentations, posters and booths at the event and the new addition of… Read More

#Exclusive Content #Opinion

#Comment #ELRIG #Genomics #Innovation #Research

Comment: Innovations for tomorrow’s drug discovery 

At the end of last month, DDW’s Megan Thomas attended ELRIG’s Research & Innovation 2022: Innovations for Tomorrow’s Drug Discovery, at The King’s Centre in Oxford, UK. The four sessions addressed aspects of innovation across drug discovery and placed an emphasis on both the digital age and novel modalities:… Read More

#Exclusive Content #News #Opinion